61. FANCONI ANEMIA Post Followup Return to Message Listings Print Message fanconi anemia Postedby Gayle (ID *****5165) Date February 02, 2003 at 172640 of 81. http://genforum.genealogy.com/sardinia/messages/81.html

Chat Daily Search My GenForum Community Standards ... Terms of Service Jump to Forum Home Regional Countries Sardinia Genealogy Forum FANCONI ANEMIA Posted by: Gayle (ID *****5165) Date: February 02, 2003 at 17:26:40 of 88 Fanconi Aplastic Anemia-a lethal genetic blood/bone marrow disease- it is a non-discriminating genetic disease. The only treatment is a bone marrow transplant. Each parent must be a carrier of the gene in order to pass the gene on to his or her child. Known Italian families this illness has presented itself. Di Lullo, Napoles, Quilici, Russo, Di Mercurio, Apollo, De Persis, Archiello, Della Ratta, Di Marino, Fiaschetti, Senatore, De Bonis, Ceresa, Briga, De Marco, Ciccolini, Frontani, Mignone, Pagano People interested in helping may become bone marrow donors to help save a child’s life. Identical matches are found in ones ethnic family. Support ongoing research through the Fanconi Anemia Research Fund , INC 1801 Willamette Street, Suite 200 Eugene, Oregon 97401 or www.fanconi.org. They support research around the world including research centers in Naples and Milan, Italy. Mille grazie, Gayle L.

62. Fanconi Anemia Complementation Group A Cells Are Hypersensitive To Chromium(VI)- fanconi anemia Complementation Group A Cells Are Hypersensitiveto Chromium(VI)Induced Toxicity. http://ehpnet1.niehs.nih.gov/docs/2002/suppl-5/773-777vilcheck/abstract.html

Search 110-S5 Table of Contents EHPS Archives Publications ... Subscribe Environmental Health Perspectives Supplements Volume 110, Number 5, October 2002 Citation in PubMed Related Articles Fanconi Anemia Complementation Group A Cells Are Hypersensitive to Chromium(VI)-Induced Toxicity Susan K. Vilcheck, Travis J. O'Brien, Daryl E. Pritchard, Linan Ha, Susan Ceryak, Jamie L. Fornsaglio, and Steven R. Patierno Department of Pharmacology, Program in Molecular and Cellular Oncology, Program in Genetics, Department of Medicine, The George Washington University Medical Center, Washington, DC, USA Full Article in HTML Full Article in PDF Abstract Key words: apoptosis, carcinogen, caspase-3, clonogenicity, DNA adducts, genotoxin, phosphatidylserine translocation, sodium chromate, uptake. Environ Health Perspect 110(suppl 5):773-777 (2002). http://ehpnet1.niehs.nih.gov/docs/2002/suppl-5/773-777vilcheck/abstract.html This article is part of the monograph Molecular Mechanisms of Metal Toxicity and Carcinogenicity Address correspondence to S.R. Patierno, Dept. of Pharmacology, The George Washington University Medical Center, 2300 Eye St., NW, Washington, DC 20037 USA. Telephone: (202) 994-3286. Fax: (202) 994-2870. E-mail:

63. Workshop On Research Directions In Fanconi Anemia Workshop on Research Directions in fanconi anemia cosponsored by theOffice of Rare Diseases at NIH. National Heart, Lung, and Blood http://rarediseases.info.nih.gov/news-reports/workshops/fanconianemia970918.html

National Heart, Lung, and Blood Institute (NHLBI) and The Office of Rare Diseases and Fanconi Anemia Research Fund, Inc. September 18 - 20, 1997 Table of Contents Executive Summary Agenda Workshop Participant List Executive Summary The Workshop on Research Directions in Fanconi Anemia was held on September 18-20, 1997 at the Columbia Inn Hotel and Conference Center in Columbia, Maryland. This important workshop resulted in attendance of individuals from across the nation and worldwide. Brief highlights from the scientific sessions and the major recommendations from the workshop are presented below. Fanconi anemia is an autosomal recessive bone marrow failure bone marrow syndrome characterized by pancytopenia, developmental defects, DNA cross linking agent hypersensitivity and cancer susceptibility. Many FA patients can be identified at birth because of congenital anomalies, although approximately 25% do not have birth defects. FA is a clinically heterogeneous disorder and can currently be divided into a least five different complementation groups designated A through E. The two cloned FA genes, FAA and FAC, encode proteins that are unrelated to each other and to other proteins in Genbank. Current research focuses on the identifying the role FA genes play in normal cells, identification and cloning new FA genes, and examining current therapies for the treatment of FA and were major topics at the workshop.

64. TAU Research Authority - Fanconi Anemia Research Fund fanconi anemia Research Fund, Inc., USA (1235) Medical Research Program - ResearchGrants 2003. Medicine, Life Sciences, Exact Sciences, Engineering. http://www.tau.ac.il/Research-Authority/announce/fanconi.html

65. Fanconi Anemia Research Fund, Inc. Return to Search Page fanconi anemia Research Fund, Inc. Email info@fanconi.org.Conditions fanconi anemia. Hours Answered 8am - 5pm Voicemail yes. http://www.geneticalliance.org/diseaseinfo/displayorganization.html?orgname=Fanc

66. 4 Fanconi Anemia Complementation Group D2 (fancd2) Knockout Mice fanconi anemia Complementation Group D2 (fancd2) knockout mice display microphthalmiaand an increased susceptibility to breast and ovarian cancer. http://www.faseb.org/genetics/ashg02s/f4.htm

67. Ask NOAH About: Anemia of Pediatrics Understanding Your Complete Blood Count National Institutes ofHealth (PDF File of 9 Pages) What is fanconi anemia and How is it Diagnosed? http://www.noah-health.org/english/illness/blood/anemia.html

Ask NOAH About: Anemia What is Anemia? Care and Treatment Information Resources Basic Descriptions Anemia in Children ... Organizations What Is Anemia? Basic Descriptions About Anemia - KidsHealth All About Anemia - Anemia Life Line Anaemia Due to Red Cell Loss - BUPA Anemia - KidsHealth ... Anemia - Methodist Healthcare System, Houston TX (also in Spanish Anemia: When Low Iron is the Cause - American Academy of Family Physicians (also in Spanish Anemia, General - Mayo Clinic Anemia in Young Women - InteliHealth Anemias - ... Women's Health: Anemia - American Institute of Preventive Medicine Blood Basics Blood - TeensHealth Facts About Blood - Methodist Healthcare System, Houston TX Introduction to Hematology - Puget Sound Blood Center Red Blood Cells - Puget Sound Blood Center ... Anemia in Pregnancy Anemia in Children About Anemia - KidsHealth Anemia - KidsHealth Aplastic Anemia - Lucile Packard Children's Hospital Hemolytic Anemia - Lucile Packard Children's Hospital ... Thalassemia Anemia in Teens Iron and Teens: A Guide to Anemia Prevention - Children's Hospital, Boston MA

68. Center For Jewish Genetic Diseases - Mount Sinai School Of Diseases fanconi anemia. Short stature is commonly observed in children and adultswith fanconi anemia, and other growth measurements may also be below normal. http://www.nfjgd.org/diseases/fanconi_anemia.shtml

69. Service Page - Pathologie Information DISEASE fanconi anemia, Synonym(s) Fanconi pancytopenia, Included disease(s) fanconi anemia type 1 fanconi anemia type 2 fanconi anemia type 3, http://orphanet.infobiogen.fr/Site/Exp.stm?Lng=GB&Expert=84

70. CAGT - Fanconi Anemia fanconi anemia. H8713; Phase I/II Study of Allogeneic Stem Cell Transplantationfor Patients with Hematologic Malignancy, Using Haploidentical http://public.bcm.tmc.edu/genetherapy/clinical/fanconi.html

Fanconi Anemia H8713; Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancy, Using Haploidentical Family Donors and Sub-Myeloablative Conditioning with Campath 1H: This protocol uses a monoclonal antibody, low dose chemotherapy and radiation in combination with haploidentical allogeneic stem cell transplantation to treat patients with hematologic malignancies who have already received a stem cell transplant or who also have other complications such as kidney, liver, or heart disease. H8875; Matched Sibling Donor Stem Cell Transplantation for Fanconi Anemia: A Joint Protocol of the FARF and the NMDP: This protocol uses chemotherapy and radiation in combination with a matched allogeneic stem cell transplantation to treat children and adults with Fanconi Anemia. H9938; CD45 (Yth-24 And Yth-54) and CD52 (Campath-1h) Monoclonal Antibody Conditioning Regimen for HLA-Identical Donor Stem Cell Transplantation of Patients with Fanconi Anemia: This protocol uses monoclonal antibodies in combination with a matched allogeneic stem cell transplantation to treat patients with Fanconi Anemia.

71. Health Library: All Topics: F: Fanconi's Anemia - Healthfinder® How is fanconi anemia Related to Leukemia and Other Cancers This document discussesfanconi anemia patients' risks of developing leukemia and other related http://www.healthfinder.gov/Scripts/SearchContext.asp?topic=305

72. The Scientist :: BRCA2 Loss In Fanconi Anemia BRCA2 loss in fanconi anemia. Analysis of fanconi anemia cell lines reveals deletionsin the breast cancer susceptibility gene BRCA2. By Jonathan B Weitzman. http://www.biomedcentral.com/news/20020614/01/

Previous Next BRCA2 loss in Fanconi Anemia Analysis of Fanconi Anemia cell lines reveals deletions in the breast cancer susceptibility gene By Jonathan B Weitzman Fanconi Anemia (FA) is a recessive cancer susceptibility syndrome. Six FA genes have been cloned and encode proteins involved in a DNA-damage response pathway. In the June 13 ScienceXpress , Niall Howlett and colleagues report the characterization of mutations in cells from the FA subtypes B and D1 ( ScienceXpress 2002, DOI:10.1126/science.1073834). They discovered biallelic mutations in the breast cancer susceptibility gene; the mutations create frameshifts resulting in truncated BRCA2 protein. Howlett et al. show that restoring expression could rescue the phenotype of FA cells and restore resistance to DNA-damaging agents. The authors propose a model linking FA-associated genes to the regulation of a common DNA-damage response pathway. Links for this article Fanconi anemia and DNA repair PubMed Abstract Interaction of the Fanconi anemia proteins and in a common pathway.

73. NORD - National Organization For Rare Disorders, Inc. General Discussion Fanconi's Anemia is a rare genetic disorder that may be apparentat birth or during childhood. fanconi anemia Research Fund, Inc. http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Anemia, Fanco

74. Fanconi Anemia Basic Molecular Biology And Clinical Implications Helmut Hanenberg, Detlev Schindler, fanconi anemia basic molecularbiology and clinical implications, Fanconi (FA) is an autosomal http://www.wissenschaft-online.de/gbm/homepage/abstract_detail.php?artikel_id=24

75. A To Z Encyclopedia Topic: Fanconi Anemia Unfortunately, at this time, we are not able to provide informationabout this condition or procedure. However, we will be frequently http://web1.tch.harvard.edu/cfapps/A2ZtopicDisplay.cfm?Topic=Fanconi Anemia

76. The Fanconi Anemia Protein FANCC Binds To And Facilitates The Activation Of STAT 2000 July; 20 (13) 4724 4735 The fanconi anemia Protein FANCC Binds to and Facilitatesthe Activation of STAT1 by Gamma Interferon and Hematopoietic Growth http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85895

77. Research On Fanconi Anemia fanconi anemia. Sectie Functionele Genoomanalyse. Joenje H, Arwert F. Connectingfanconi anemia to BRCA1. Nat Med 2001 Apr;7(4)4067. PubMed ID 11283658. http://www.med.vu.nl/kga/ondz_fanc.html

Fanconi anemia Sectie Functionele Genoomanalyse With the 1992 landmark publications by Manuel Buchwald's group in Toronto reporting 4 complementation groups (in 7 FA patients) and expression cloning of the first FA gene ( FANCC ) we decided to embark on the genetic approach. Thus, after a 3-months sabbatical in Buchwald's laboratory (H.J.) a collaborative research line was initiated aiming at extended complementation studies and gene cloning. In addition, we initiated and participated in a EU-sponsored Concerted Action EUFAR (1994 -1996) which allowed us to establish a Cell Repository for cell material from FA patients diagnosed in European countries and elsewhere. This facility enabled us to carry out complementation analysis on patients from diverse ethnic backgrounds, which led to the recognition of 8 complementation groups, mapping of the FANCA gene and cloning of FANCA, FANCG, FANCF

78. OMIM - FANCONI ANEMIA COMPLEMENTATION GROUP A GENE; FANCA http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607139

79. OMIM - FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1 http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=605724

80. Hematopoietic Stem Cell Biology And Gene Therapy For Fanconi Anemia Translate this page Alérion Hematopoietic stem cell biology and gene therapy for fanconi anemia. http://www.ulaval.ca/vrr/rech/Proj/74580.html

Hematopoietic stem cell biology and gene therapy for Fanconi anemia Subvention Instituts de recherche en santé du Canada Subventions de fonctionnement Description Domaine(s) de recherche Anémies Sang Chercheur(s) Madeleine Carreau , Médecine, Département de pédiatrie, responsable du projet Tranche(s) de financement Instituts de recherche en santé du Canada Date de fin: Demande de correction

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 105    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20